FDA Archives - Page 21 of 24

Podcast: KHN’s ‘What The Health?’ Congress And Health Care. Again.

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Alice Ollstein of Talking Points Memo and Kimberly Leonard of the Washington Examiner talk about the new push on health legislation by Republicans in the House, as well as developments on Medicaid work requirements, drug prices and the fate of children separated from their parents at the U.S.-Mexican border. Plus, for extra credit, the panelists offer their favorite health stories of the week.

July 26, 2018

Must-Reads Of The Week From Brianna Labuskes

KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

July 6, 2018

Top Policy Expert’s Ties To Giant Drugmaker Often Go Unstated

Dr. Mark McClellan joined Johnson & Johnson’s board of directors after leaving the FDA, but the connection often isn’t mentioned in research papers or public events.

By Sarah Jane Tribble

June 29, 2018

Bubble Pop? Brownie Batter? Vapes’ Added Flavors Fuel E-Cig Debate

Vaping is becoming increasingly popular in the United States, especially among young people. This fact is triggering an unexpected divide within the public health community and complicating efforts to regulate the industry.

By Shefali Luthra

June 4, 2018

Drugmakers Blamed For Blocking Generics Have Jacked Up Prices And Cost U.S. Billions

The Trump administration is shaming brand-name drugmakers who refuse to sell samples so generics can be made from their products.

By Sydney Lupkin

May 23, 2018

Best Reads Of The Week With Brianna Labuskes

KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

May 18, 2018

Today’s Special: Obamacare Menu Labeling Rules Ushered In

Restaurants, convenience stores, vending machines and pizza delivery services are among the businesses that will have to provide calories counts to consumers.

By Phil Galewitz

May 7, 2018

Dissecting The Rhetoric Vs. Reality Of Trump’s Tough Talk On Drug Prices

President Donald Trump’s upcoming speech on drug prices comes after months of public comments and debate about tackling the issue.

By Sarah Jane Tribble

April 27, 2018

Study: Nearly Three-Quarters Of Commonly Used Medical Scopes Tainted By Bacteria

The ‘scary’ findings show a discouraging lack of progress in cleaning the devices, despite more vigorous efforts in the wake of deadly superbug outbreaks, experts say.

By Chad Terhune

April 23, 2018

Safety Violations Compound Pain Of Painkiller Shortages

California and federal officials have cracked down on a major compounding pharmacy they say posed a threat to public safety, but their actions are worsening shortages of medications that doctors rely on to keep their patients out of pain.

By Pauline Bartolone

April 16, 2018

Medical Marijuana’s ‘Catch-22’: Federal Limits On Research Hinder Patients’ Relief

Suffering Americans seek medical marijuana as an alternative to opioids and other powerful pharmaceuticals. Though legal in 29 states, some doctors say the lack of strong data makes it hard to recommend.

By Marisa Taylor and Melissa Bailey

April 12, 2018

C-SPAN: FDA Commissioner Scott Gottlieb Talks To KHN

Kaiser Health News reporter Sarah Jane Tribble sat down with Food and Drug Administration Commissioner Scott Gottlieb on C-SPAN’s "Newsmakers" program. The conversation ranged from how the nation should combat the opioid epidemic to reining in drug prices.

April 9, 2018

Podcast: KHN’s ‘What The Health?’ Health Law Fix Misses The Spending Bill Train

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Margot Sanger-Katz of The New York Times discuss the apparent demise of bipartisan legislation aimed at shoring up parts of the Affordable Care Act. They also discuss aggressive new efforts by the Food and Drug Administration to regulate tobacco products. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.

March 23, 2018

FDA Moves To Cut Nicotine In Cigarettes, Helping Smokers Kick Habit

In a historic move, the Food and Drug Administration stated its intent Thursday to require tobacco companies to cut nicotine levels in their products to make them less addictive. Stripping cigarettes of addictive power could lead an estimated 5 million adults to quit smoking within a year of the plan.

By Liz Szabo

March 15, 2018

In An Effort To Curb Drug Costs, States Advance Bills To Prod Feds On Importation

Legislatures in blue and red states alike are considering proposals that would allow them to import prescription drugs from Canada.

By Shefali Luthra

Feb. 16, 2018

FDA Head Vows To Tackle High Drug Prices And Drugmakers ‘Gaming The System’

In an exclusive interview, FDA Commissioner Scott Gottlieb describes what he’s doing to spur competition and bring down drug prices.

By Sarah Jane Tribble and Liz Szabo

Feb. 15, 2018

How The Shutdown Might Affect Your Health

For some federal health programs, a shuttered government means business as usual. But the congressional impasse over funding will hit others hard.

By KFF Health News Staff

Jan. 19, 2018

Investigation

Grassley Calls For ‘Corrective Action’ On Abuses In Herpes Vaccine Research

The Republican senator sent out letters to the Food and Drug Administration and HHS demanding an explanation about a rogue herpes vaccine trial.

By Marisa Taylor

Jan. 5, 2018

The Orphan Drug Machine

FDA Chief Says He’s Open To Rethinking Incentives On Orphan Drugs

The FDA’s Scott Gottlieb says the agency is focused on the big picture, and he wants to know why pharma churns out drugs for some rare diseases but not for others.

By Sarah Jane Tribble

Dec. 22, 2017